Nearly two-thirds (62%) of people with cancer want to know about complementary therapies such as exercise, nutrition counseling, massage, and meditation before starting conventional treatment, but only 33% of oncologists ...
Nov 15, 2022
0
6
Treating high-risk, asymptomatic bone metastases with radiation may reduce painful complications and hospitalizations and possibly extend overall survival in people whose cancer has spread to multiple sites, a phase II clinical ...
Oct 23, 2022
0
15
October is National Breast Cancer Awareness Month, and a new national survey commissioned by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute ...
Oct 12, 2022
0
27
Results of a study led by VHIO investigators and published in Nature Medicine have unmasked mutations in the RNF43 gene as predictive biomarkers of response to treatment with anti-BRAF/EGFR combinatory therapy in patients ...
Sep 27, 2022
0
35
In prostate cancer patients experiencing recurrence following a radical prostatectomy, imaging with 18F-DCFPyL PSMA PET/CT has been shown to considerably improve detection of active disease as compared to imaging with CT ...
Sep 7, 2022
0
19
My oncologist has one of those little motivational prints hanging on his waiting room wall, with the simple statement: "trust your instincts." One day, bored with the long purgatory of the waiting room, I tweet this news ...
Aug 4, 2022
0
16
Children with high-risk neuroblastoma had worse outcomes if they were from certain racial/ethnic groups, or were on public rather than private insurance, despite being treated in clinical trials with standardized protocols, ...
Jun 1, 2022
0
8
Children with high-risk neuroblastoma had worse outcomes if they were from certain racial/ethnic groups or were on public rather than private insurance, despite being treated in clinical trials with standardized protocols, ...
May 26, 2022
0
4
Researchers at The University of Texas MD Anderson Cancer Center have identified a novel strategy to reduce immune-related adverse events from immunotherapy treatment by targeting the cytokine interleukin-6 (IL-6). The study, ...
May 9, 2022
0
44
CAR-T therapy, a form of immunotherapy that revs up T-cells to recognize and destroy cancer cells, has revolutionized the treatment of blood cancers, including certain leukemias, lymphomas, and most recently, multiple myeloma. ...
Apr 28, 2022
0
4
